Can Geron Corporation Recover From Its Breakup With Johnson & Johnson?

Plenty of biotech investors have been feeling distraught after Johnson & Johnson (NYSE: JNJ) walked away from a four-year relationship with Geron Corporation (NASDAQ: GERN)despite several nuggets of encouraging data for the program that suggest its continued development is worth a shot.